Total submissions: 33
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000083086 | SCV001161525 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-06-18 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 2.83E-31 |
Invitae | RCV000043820 | SCV000071833 | benign | Hereditary breast ovarian cancer syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000083086 | SCV000154070 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-02-17 | criteria provided, single submitter | literature only | |
Ambry Genetics | RCV000128939 | SCV000172813 | benign | Hereditary cancer-predisposing syndrome | 2014-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CSER _CC_NCGL, |
RCV000148429 | SCV000190128 | likely benign | Breast neoplasm | 2014-06-01 | criteria provided, single submitter | research | |
Gene |
RCV000034430 | SCV000210561 | likely benign | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16847550, 20104584, 22505045, 11241844, 25569433, 23231788, 26625824, 24916970, 15955690, 16826315, 19471317, 20127978, 18724707, 22703879, 16760289, 20694749, 25637381, 26306726, 24489791, 18559594, 15983021, 24055113, 21952622, 21702907, 21520273, 24082139, 27153395, 26332594, 12474142, 27621404, 28283652, 30254663) |
CHEO Genetics Diagnostic Laboratory, |
RCV000768619 | SCV000219301 | likely benign | Breast and/or ovarian cancer | 2023-05-05 | criteria provided, single submitter | clinical testing | |
Michigan Medical Genetics Laboratories, |
RCV000083086 | SCV000267746 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-04-21 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000043820 | SCV000267842 | likely benign | Hereditary breast ovarian cancer syndrome | 2016-04-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000168548 | SCV000301757 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000083086 | SCV000383633 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2018-05-01 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000405614 | SCV000383634 | likely benign | Fanconi anemia complementation group D1 | 2018-05-01 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000043820 | SCV000494366 | benign | Hereditary breast ovarian cancer syndrome | 2014-10-20 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000168548 | SCV000538494 | uncertain significance | not specified | 2016-06-16 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: ClinVar: 8 labs classify as B/LB |
Genetic Services Laboratory, |
RCV000168548 | SCV000593703 | likely benign | not specified | 2017-02-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000034430 | SCV000602852 | likely benign | not provided | 2023-09-26 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000128939 | SCV000683428 | likely benign | Hereditary cancer-predisposing syndrome | 2015-02-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000083086 | SCV000743261 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000083086 | SCV000744412 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000083086 | SCV001139002 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000034430 | SCV001247639 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | BRCA2: BP4 |
Sema4, |
RCV000128939 | SCV002533238 | benign | Hereditary cancer-predisposing syndrome | 2020-08-06 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000168548 | SCV002550280 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000083086 | SCV004846927 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034430 | SCV000043197 | probably not pathogenic | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Likely benign. |
Sharing Clinical Reports Project |
RCV000083086 | SCV000115160 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000083086 | SCV000145881 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000168548 | SCV000591750 | benign | not specified | no assertion criteria provided | clinical testing | Borg_2010 Capanu_2011 Cavallone_2010 Edwards_2001 Edwards_2003 Giannini_2006 Haffty_2006 Peixoto_2006 Soegaard_2008 Morgan_2010 | |
Diagnostic Laboratory, |
RCV000083086 | SCV000733231 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000128939 | SCV000886671 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-09 | no assertion criteria provided | clinical testing | |
Clinical Genetics Laboratory, |
RCV000168548 | SCV001905752 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000168548 | SCV001951491 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000034430 | SCV002036681 | likely benign | not provided | no assertion criteria provided | clinical testing |